These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7760842)

  • 1. A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat.
    Gualberto A; Hixon ML; Finco TS; Perkins ND; Nabel GJ; Baldwin AS
    Mol Cell Biol; 1995 Jun; 15(6):3450-9. PubMed ID: 7760842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat.
    Gualberto A; Baldwin AS
    J Biol Chem; 1995 Aug; 270(34):19680-3. PubMed ID: 7649977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
    Li CJ; Wang C; Friedman DJ; Pardee AB
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5461-4. PubMed ID: 7777531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-Dependent and -independent transactivation by the E6 protein of human papillomavirus type 16.
    Akutsu N; Shirasawa H; Asano T; Isono K; Simizu B
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():459-63. PubMed ID: 8601782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of cellular and viral promoters by p73 and p53.
    Deb D; Lanyi A; Scian M; Keiger J; Brown DR; Le Roith D; Deb SP; Deb S
    Int J Oncol; 2001 Feb; 18(2):401-9. PubMed ID: 11172610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
    Duan L; Ozaki I; Oakes JW; Taylor JP; Khalili K; Pomerantz RJ
    J Virol; 1994 Jul; 68(7):4302-13. PubMed ID: 8207805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
    Zambetti GP; Bargonetti J; Walker K; Prives C; Levine AJ
    Genes Dev; 1992 Jul; 6(7):1143-52. PubMed ID: 1628822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
    Torgeman A; Mor-Vaknin N; Zelin E; Ben-Aroya Z; Löchelt M; Flügel RM; Aboud M
    Virology; 2001 Mar; 281(1):10-20. PubMed ID: 11222091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
    Ludes-Meyers JH; Subler MA; Shivakumar CV; Munoz RM; Jiang P; Bigger JE; Brown DR; Deb SP; Deb S
    Mol Cell Biol; 1996 Nov; 16(11):6009-19. PubMed ID: 8887630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.
    Hannibal MC; Markovitz DM; Clark N; Nabel GJ
    J Virol; 1993 Aug; 67(8):5035-40. PubMed ID: 8331739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.
    Mori N; Kashanchi F; Prager D
    Blood; 1997 Dec; 90(12):4924-32. PubMed ID: 9389710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel p53 transcriptional repressor element (p53TRE) and the asymmetrical contribution of two p53 binding sites modulate the response of the placental transforming growth factor-beta promoter to p53.
    Wong J; Li PX; Klamut HJ
    J Biol Chem; 2002 Jul; 277(29):26699-707. PubMed ID: 12011055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.
    Aoyama N; Nagase T; Sawazaki T; Mizuguchi G; Nakagoshi H; Fujisawa JI; Yoshida M; Ishii S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5403-7. PubMed ID: 1535157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of DNA binding sites by mutant p53 proteins.
    Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
    Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.